Marksans Pharma Limited(IN:MARKSANS)
₹306.45-2.15 (-0.70%)
IN:MARKSANS
Marksans Pharma Limited Revenue
₹306.45
At close:-2.15 (-0.70%)
Want to see IN:MARKSANS full AI Analyst Report?
Marksans Pharma Limited (MARKSANS) Revenue
8 Followers
Marksans Pharma Limited Revenue
Marksans Pharma Limited had a revenue of 8.41B in the quarter ending Jun 30, 2026, with -1.79%. This bring the company's revenue in the last twelve months to 31.72B, Increased 7.48%. In the fiscal year ending Mar 31, 2026, Marksans Pharma Limited had annual revenue of 29.51B with 12.51% growth.
- Revenue (ttm)
- 31.72B
- Revenue Growth
- 24.20%
- P/S Ratio
- 4.74
- Revenue/Employee
- INR 17,512,985
- Employees
- 1,685
- Market Cap
- INR 139.85B
Revenue Chart
Marksans Pharma Limited Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 29.51B | 3.28B | 12.51% |
| Mar 31, 2025 | 26.23B | 4.45B | 20.46% |
| Mar 31, 2024 | 21.77B | 3.25B | 17.56% |
| Mar 31, 2023 | 18.52B | 3.72B | 25.13% |
| Mar 31, 2022 | 14.80B | 1.12B | 8.17% |
| Mar 31, 2021 | 13.68B | 2.39B | 21.17% |
| Mar 31, 2020 | 11.29B | 1.42B | 14.38% |
| Mar 31, 2019 | 9.87B | 746.40M | 8.18% |
| Mar 31, 2018 | 9.13B | 1.46B | 18.97% |
| Mar 31, 2017 | 7.67B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.